Emerging social network Foursquare plans to launch a partnership with Zagat (PR Week)
Takeda Launches Osteosarcoma Medicine Mepact in EU (Oncology Weekly)
FDA OK’s Wider Use of AstraZeneca’s Crestor (PharmaTimes)
Novartis buys rights to Debiopharm’s “Hep C” drug (PharmaTimes)
Teva Settles U.S. Drug Pricing Laws (PharmaTimes)
Alzheimer’s drug Dimebeon may help Huntington’s Patients (PharmaTimes)
Eli Lilly CEO’s Total Pay Rose to $20.9 million in 2009 (Indianapolis Star)
Biogen 4Q Profit Grows 48 Percent On Tysabri Sales (Associated Press)
SUBSCRIBE